awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34539519-5DF7B488-CD8B-4482-88AA-00B4716698B3
Q34539519-5DF7B488-CD8B-4482-88AA-00B4716698B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34539519-5DF7B488-CD8B-4482-88AA-00B4716698B3
Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: findings using real-world claims data.
P2860
Q34539519-5DF7B488-CD8B-4482-88AA-00B4716698B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34539519-5DF7B488-CD8B-4482-88AA-00B4716698B3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c163f714b89d737dfcfaa5b37d56623439c42a6
P2860
The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide mai